Chronic lymphocytic leukemia-associated refractory immune thrombocytopenia successfully treated with eltrombopag

Case report OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This case report describes a patient with CLL and refractory ITP experiencing major bleeding, who achieved normal platelet counts and stopped bleeding after treatment with eltrombopag.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Chronic lymphocytic leukemia (CLL) may be associated with immune thrombocytopenia (ITP). The standard treatment for CLL-associated ITP is steroids. For refractory cases, various treatment strategies such as rituximab, splenectomy, and thrombopoietic mimetics are available. We report a patient with CLL who developed recurrent ITP and life-threatening pulmonary hemorrhage. Platelet counts remained extremely low despite massive platelet transfusion and treatment including steroids, immunoglobulin, and single-dose rituximab infusion. The bleeding stopped and platelet counts were increased to normal range 13 days after treatment with eltrombopag 25 mg per day. Our experience suggests that eltrombopag is an effective treatment option in CLL-associated, refractory ITP, especially during major bleeding, which requires relatively rapid improvement of thrombocytopenia.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Benzoates Hemorrhage Hydrazines Leukemia, Lymphocytic, Chronic, B-Cell Lung Diseases Pyrazoles Thrombocytopenia Thrombocytopenia Adrenal Cortex Hormones Adrenal Cortex Hormones Aged Antibodies, Monoclonal, Murine-Derived Antibodies, Monoclonal, Murine-Derived Benzoates Hemorrhage Hemorrhage Humans Hydrazines Immunoglobulins Immunoglobulins

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (87)

Cited by (1)

Source provenance

crossref
last seen: 2026-05-18T01:00:16.558261+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:15:04.544443+00:00
License: CC0 · commercial use OK